Can a state do that? There must be some federal control of how funds are allocated. What inhumane monsters DeSantos and his minions are:
Transgender Floridians of all ages will soon no longer be able to use Medicaid to help pay for gender-affirming care under a new state rule, a move that comes as Gov. Ron DeSantis’s administration pursues policies increasing restrictions on medical treatments like puberty blockers and hormone therapy.
Florida joins at least 10 other states — including Arizona, Missouri and Texas — in barring residents from using Medicaid to pay for several often-prescribed medications and surgeries for those diagnosed with gender dysphoria. The rule was published Wednesday and is slated to go into effect August 21.
Florida’s move is a “major change” that is going to disrupt low-income members of the transgender community who have been receiving treatment through Medicaid for years, said Carl Charles, senior attorney of the Southern Regional Office for Lambda Legal, an LGBTQ advocacy group. He said his group was “alarmed” to see the measure come so quickly and that “people would be right to assume” the move has the stamp of approval from DeSantis, who is widely considered a potential 2024 Republican candidate for president.
Brock Juarez, a spokesman for the Florida’s Agency for Health Care Administration, the agency overseeing the state’s Medicaid program, did not immediately return requests for comment.
Lambda Legal is “exploring all options” to challenge the rule, Charles said.
“It’s gut-wrenching,” he said. “People have made a decision in their lives to pursue a course of care that’s going to be life-changing, and now they’re facing the potential that they may not be able to move forward with that.”
Earlier this year, Florida Surgeon General Joseph Ladapo released a memo to the state’s health-care workers advising providers against providing gender-affirming treatments, such as puberty blockers, to minors. The memo also advised against social transition — a nonmedical process in which a person changes their clothing, name or pronouns to better align with their gender identity. Ladapo wrote that this should “not be a treatment option for children or adolescents.”
The country’s largest medical organizations, including the American Academy of Pediatrics, the Endocrine Society and the American Academy of Child and Adolescent Psychiatry recommend gender-affirming care to help treat minors experiencing gender dysphoria — a condition in which a person experiences psychological distress because their biological sex and gender identity do not align.
Gender-affirming care can, but does not always, include medical interventions. The most common treatments for adolescents include puberty blockers, which are reversible, and hormone replacement therapy. According to current standards, genital surgeries are not recommended for patients under the age of 18. In April, 300 medical providers in the state wrote an open letter in the Tampa Bay Times criticizing the state’s guidance against gender-affirming care.
FAQ: What you need to know about transgender children
“Florida was really the first state to come for the throat of the medical evidence behind gender-affirming care, to create this false narrative that there is not sufficient evidence to support the benefits,” said Meredithe McNamara, an assistant professor at Yale’s School of Medicine, who worked with a team of researchers to review Florida’s medical report on the issue.
“We are alarmed that Florida’s health care agency has adopted a purportedly scientific report that so blatantly violates the basic tenets of scientific inquiry,” the report’s authors wrote.
State medical boards historically have not decided policy or standards of care, McNamara said. Instead, their work tends to focus on issues like licensing or reviewing complaints against physicians. AHCA’s Medicaid decision, as well as its impending rule changes, she said, are “really unusual and concerning to the medical community.”
In a post-Roe world, “it’s kind of terrifying to think about the precedent that this might set," McNamara added.
Transgender Floridians of all ages will soon no longer be able to use Medicaid to help pay for gender-affirming care under a new state rule, a move that comes as Gov. Ron DeSantis’s administration pursues policies increasing restrictions on medical treatments like puberty blockers and hormone therapy.
Florida joins at least 10 other states — including Arizona, Missouri and Texas — in barring residents from using Medicaid to pay for several often-prescribed medications and surgeries for those diagnosed with gender dysphoria. The rule was published Wednesday and is slated to go into effect August 21.
Florida’s move is a “major change” that is going to disrupt low-income members of the transgender community who have been receiving treatment through Medicaid for years, said Carl Charles, senior attorney of the Southern Regional Office for Lambda Legal, an LGBTQ advocacy group. He said his group was “alarmed” to see the measure come so quickly and that “people would be right to assume” the move has the stamp of approval from DeSantis, who is widely considered a potential 2024 Republican candidate for president.
Brock Juarez, a spokesman for the Florida’s Agency for Health Care Administration, the agency overseeing the state’s Medicaid program, did not immediately return requests for comment.
Lambda Legal is “exploring all options” to challenge the rule, Charles said.
“It’s gut-wrenching,” he said. “People have made a decision in their lives to pursue a course of care that’s going to be life-changing, and now they’re facing the potential that they may not be able to move forward with that.”
Earlier this year, Florida Surgeon General Joseph Ladapo released a memo to the state’s health-care workers advising providers against providing gender-affirming treatments, such as puberty blockers, to minors. The memo also advised against social transition — a nonmedical process in which a person changes their clothing, name or pronouns to better align with their gender identity. Ladapo wrote that this should “not be a treatment option for children or adolescents.”
The country’s largest medical organizations, including the American Academy of Pediatrics, the Endocrine Society and the American Academy of Child and Adolescent Psychiatry recommend gender-affirming care to help treat minors experiencing gender dysphoria — a condition in which a person experiences psychological distress because their biological sex and gender identity do not align.
Gender-affirming care can, but does not always, include medical interventions. The most common treatments for adolescents include puberty blockers, which are reversible, and hormone replacement therapy. According to current standards, genital surgeries are not recommended for patients under the age of 18. In April, 300 medical providers in the state wrote an open letter in the Tampa Bay Times criticizing the state’s guidance against gender-affirming care.
FAQ: What you need to know about transgender children
“Florida was really the first state to come for the throat of the medical evidence behind gender-affirming care, to create this false narrative that there is not sufficient evidence to support the benefits,” said Meredithe McNamara, an assistant professor at Yale’s School of Medicine, who worked with a team of researchers to review Florida’s medical report on the issue.
“We are alarmed that Florida’s health care agency has adopted a purportedly scientific report that so blatantly violates the basic tenets of scientific inquiry,” the report’s authors wrote.
State medical boards historically have not decided policy or standards of care, McNamara said. Instead, their work tends to focus on issues like licensing or reviewing complaints against physicians. AHCA’s Medicaid decision, as well as its impending rule changes, she said, are “really unusual and concerning to the medical community.”
In a post-Roe world, “it’s kind of terrifying to think about the precedent that this might set," McNamara added.